IL1B and viral infectious disease: Despite reducing both viral infection and release, oseltamivir had no effect on the secretion of these mediators, with the exception of IL-1β and TNF-α, which were reduced by ∼50% (Fig. 6A), and only TNF-α was reduced to its baseline level.